Safe exposure level for diacetyl

References

• Egilman D, Schilling E. NIOSH diacetyl REL hearing slides [document on the Internet]. Atlanta (GA): NIOSH; 2011 [cited 2013 Aug 16]. Available from: http://www.cdc.gov/niosh/docket/archive/pdfs/NIOSH-245/0245-082611-Egilman_pres.pdf
   Google Scholar
• Egilman DS, Schilling JH, Menendez L. A proposal for a safe exposure level for diacetyl. Int J Occup Environ Health. 2011;17(2):122–34.
   PubMed Web of Science ®Google Scholar
• Wallace KB. ToxDx. Consumer safety estimate for inhalation of synthetic butter flavoring components of microwave-ready popcorn. Submitted 4/21/2005 by Kendall B. Wallace, Ph.D., DABT. Produced in ‘Newkirk vs. ConAgra Foods, Inc., et al.’ Case 2:08-cv-00273-RMP. 2005.
   Google Scholar
• Wallace K, Veith GD. Rebuttal to the remarks by Dr. Egilman and correction of the errors in his interpretation of the calculated LUMO values and their application to setting safe levels for diacetyl and 2,3-pentandione. Atlanta (GA): NIOSH; 2011.
   Google Scholar
• ACGIH. Diacetyl: TLV® chemical substances 7th edition documentation. Cincinnati (OH): ACGIH; 2012; Diacetyl: TLV® chemical substances 7th edition documentation. Cincinnati (OH): ACGIH; 2013.
   Google Scholar
• NIOSH. Criteria for a recommended standard: occupational exposure to diacetyl and 2,3-pentanedione [Internet]. Atlanta (GA): NIOSH; 2011. Available from: http://www.cdc.gov/niosh/docket/archive/docket245.html, accessed on November 23, 2013.
   Google Scholar
• Maier A, Kohrman-Vincent M, Parker A, Haber LT. Evaluation of concentration-response options for diacetyl in support of occupational risk assessment. Regul Toxicol Pharmacol. 2010;58(2):285–96.
   PubMed Web of Science ®Google Scholar
• Mathews JM, Watson SL, Snyder RW, Burgess JP, Morgan DL. Reaction of the butter flavorant diacetyl (2,3-butanedione) with N-alpha-acetylarginine: a model for epitope formation with pulmonary proteins in the etiology of obliterative bronchiolitis. J Agric Food Chem. 2010;58(24):12761–8.
   PubMed Web of Science ®Google Scholar
• Sun LZ, Elsayed S, Bronstad AM, van Do T, Irgens A, Aardal NP, . Airway inflammation and bronchial remodelling in toluene diisocyanate-exposed BALB/c mouse model. Scand J Immunol. 2007;65(2):118–25.
   PubMed Web of Science ®Google Scholar
• Fujioka K, Shibamoto T. Determination of toxic carbonyl compounds in cigarette smoke. Environ Toxicol. 2006;21(1):47–54.
   PubMed Web of Science ®Google Scholar
• Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med. 1974;291(15):755–8.
   PubMed Web of Science ®Google Scholar
• Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, . Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67(10):1488–92.
   PubMed Web of Science ®Google Scholar
• Stensland M, Holm A, Kiehne A, Fleckenstein B. Targeted analysis of protein citrullination using chemical modification and tandem mass spectrometry. Rapid Commun Mass Spectrom. 2009;23(17):2754–62.
   PubMed Web of Science ®Google Scholar
• de Ceuleneer M, de Wit V, van Steendam K, van Nieuwerburgh F, Tilleman K, Deforce D. Modification of citrulline residues with 2,3-butanedione facilitates their detection by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2011;25(11):1536–42.
   PubMed Web of Science ®Google Scholar
• Moelants EA, van Damme J, Proost P. Detection and quantification of citrullinated chemokines. PloS ONE. 2011;6(12):e28976.
   Google Scholar
• Fischer A, Solomon JJ, du Bois RM, Deane KD, Olson AL, Fernandez-Perez ER, . Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med. 2012;106(7):1040–7.
   PubMed Web of Science ®Google Scholar
• Giles JT, Danoff SK, Sokolove J, Wagner CA, Winchester R, Pappas DA, . Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheum Dis. 2013 May 28.</othinfo>
   Web of Science ®Google Scholar
• Szodoray P, Szabó Z, Kapitány A, Gyetvai A, Lakos G, Szántó S, . Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev. 2010;9(3):140–3.
   PubMed Web of Science ®Google Scholar
• Rosati JA, Krebs KA, Liu X. Emissions from cooking microwave popcorn. Crit Rev Food Sci Nutr. 2007;47(8):701–9.
   PubMed Web of Science ®Google Scholar
• Morgan DL, Jokinen MP, Price HC, Gwinn WM, Palmer SM, Flake GP. Bronchial and bronchiolar fibrosis in rats exposed to 2,3-pentanedione vapors: implications for bronchiolitis obliterans in humans. Toxicol Pathol. 2012;40(3):448–65.
   PubMed Web of Science ®Google Scholar
• Egilman DS, Schilling JH. Bronchiolitis obliterans and consumer exposure to butter-flavored microwave popcorn: a case series. Int J Occup Environ Health. 2012;18(1):29–42.
   PubMed Web of Science ®Google Scholar
• Elci OC, Enright PL, Simoes JE, Boylstein R, Kreiss K. Repeated short-duration, high-intensity exposure and airways obstruction in popcorn production workers. Presented at ATSIC, Seattle, WA, USA, May 2003.
   Google Scholar
• Cigarettes LFE [Internet]. 2010 [cited 2013 Oct 8]. Available from: http://www.webcitation.org/5x5pj4AXH
   Google Scholar
• Fowler EH, Dodd DE. Respiratory tract changes in guinea pigs, rats, and mice following a single six-hour exposure to methyl isocyanate vapor. Environm Health Perspect. 1987;72:109–16.
   PubMed Web of Science ®Google Scholar
• Fowler EH, Dodd DE. Acute inhalation studies with methyl isocyanate vapor. II. Respiratory tract changes in guinea pigs, rats, and mice. Fundam Appl Toxicol. 1986;6(4):756–71.
   PubMedGoogle Scholar
• Burge P, Robertson A, Cullinan P, Howell T. Obliterative bronchiolitis in boatbuilders exposed to styrene and isocyanates. Am J Respir Crit Care Med. 2008;177:a157.
   Google Scholar
• Schnorr TM, Steenland K, Egeland GM, Boeniger M, Egilman D. Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry. Occup Environ Med. 1996;53(10):703–7.
   PubMed Web of Science ®Google Scholar
• Sorahan T, Pope D. Mortality and cancer morbidity of production workers in the United Kingdom flexible polyurethane foam industry. Br J Ind Med. 1993;50(6):528–36.
   PubMedGoogle Scholar
• Sorahan T, Nichols L. Mortality and cancer morbidity of production workers in the UK flexible polyurethane foam industry: updated findings, 1958–98. Occup Environ Med. 2002;59(11):751–8.
   PubMed Web of Science ®Google Scholar
• Mikoczy Z, Welinder H, Tinnerberg H, Hagmar L. Cancer incidence and mortality of isocyanate exposed workers from the Swedish polyurethane foam industry: updated findings 1959–98. Occup Environ Med. 2004;61(5):432–7.
   PubMed Web of Science ®Google Scholar